Mosaic ImmunoEngineering, Inc. (CPMV)

OTCMKTS · Delayed Price · Currency is USD
0.520
-0.034 (-6.14%)
At close: Mar 5, 2026
-46.33%
Market Cap 3.77M
Revenue (ttm) n/a
Net Income (ttm) -671.75K
Shares Out 7.24M
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 205
Average Volume 872
Open 0.520
Previous Close 0.554
Day's Range 0.520 - 0.520
52-Week Range 0.252 - 1.050
Beta -0.78
RSI 50.13
Earnings Date Feb 27, 2026

About Mosaic ImmunoEngineering

Mosaic ImmunoEngineering, Inc., a development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer. It engages in pursuing new product candidates and platforms to build a new pipeline based on immunotherapies. Mosaic ImmunoEngineering, Inc. was founded in 2020 and is based in Huntington Beach, California. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2020
Employees 8
Stock Exchange OTCMKTS
Ticker Symbol CPMV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.